364 related articles for article (PubMed ID: 16515974)
21. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.
Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ
Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
23. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
24. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
Schumacher MC; Holmäng S; Davidsson T; Friedrich B; Pedersen J; Wiklund NP
Eur Urol; 2010 Feb; 57(2):293-9. PubMed ID: 19913351
[TBL] [Abstract][Full Text] [Related]
25. A re-staging transurethral resection predicts early progression of superficial bladder cancer.
Herr HW; Donat SM
BJU Int; 2006 Jun; 97(6):1194-8. PubMed ID: 16566813
[TBL] [Abstract][Full Text] [Related]
26. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
27. [T1 bladder tumors: value of a second endoscopic resection].
Rigaud J; Karam G; Braud G; Glemain P; Buzelin JM; Bouchot O
Prog Urol; 2002 Feb; 12(1):27-30. PubMed ID: 11980011
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic factors of superficial bladder cancer recurring after initial transurethral resection].
Nakata S; Nakano K; Takahashi H; Shimizu K
Hinyokika Kiyo; 2005 Apr; 51(4):229-33. PubMed ID: 15912780
[TBL] [Abstract][Full Text] [Related]
29. [A clinicopathological study on patients with bladder cancer treated with cystectomy].
Yamashita S; Taniguchi K; Suzu H; Yushita Y; Sakuragi T; Kanetake H; Shindo K; Saito Y; Hori T; Tasaki T
Hinyokika Kiyo; 1990 Oct; 36(10):1149-54. PubMed ID: 2264543
[TBL] [Abstract][Full Text] [Related]
30. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
[TBL] [Abstract][Full Text] [Related]
31. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
32. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.
Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW
BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782
[TBL] [Abstract][Full Text] [Related]
33. Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Lotan Y; Vazina A; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP;
J Urol; 2006 May; 175(5):1645-9; discussion 1649. PubMed ID: 16600721
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
35. The value of a second transurethral resection in evaluating patients with bladder tumors.
Herr HW
J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
[TBL] [Abstract][Full Text] [Related]
36. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
37. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
38. Impact of a second transurethral resection on the staging of T1 bladder cancer.
Dalbagni G; Herr HW; Reuter VE
Urology; 2002 Nov; 60(5):822-4; discussion 824-5. PubMed ID: 12429307
[TBL] [Abstract][Full Text] [Related]
39. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
[TBL] [Abstract][Full Text] [Related]
40. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course.
Takashi M; Sakata T; Murase T; Hamajima N; Miyake K
Nagoya J Med Sci; 1991 Mar; 53(1-4):1-8. PubMed ID: 1805133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]